The potential role of SARS-CoV-2 infection and vaccines in multiple Sclerosis onset and reactivation: a case series and literature review
E Tavazzi, A Pichiecchio, E Colombo, E Rigoni… - Viruses, 2023 - mdpi.com
The recent SARS-CoV-2 pandemic and related vaccines have raised several issues. Among
them, the potential role of the viral infection (COVID-19) or anti-SARS-CoV-2 vaccines as …
them, the potential role of the viral infection (COVID-19) or anti-SARS-CoV-2 vaccines as …
Multiple sclerosis, COVID-19 and vaccines: making the point
S Toscano, CG Chisari, F Patti - Neurology and Therapy, 2021 - Springer
Abstract On 11 March 2020, the World Health Organization declared the coronavirus
disease 19 (COVID-19) outbreak a pandemic. In this context, several studies and clinical …
disease 19 (COVID-19) outbreak a pandemic. In this context, several studies and clinical …
COVID-19: the course, vaccination and immune response in people with multiple sclerosis: systematic review
M Bazylewicz, M Gudowska-Sawczuk… - International Journal of …, 2023 - mdpi.com
When the Coronavirus Disease 2019 (COVID-19) appeared, it was unknown what impact it
would have on the condition of patients with autoimmunological disorders. Attention was …
would have on the condition of patients with autoimmunological disorders. Attention was …
Multiple sclerosis patients and disease modifying therapies: impact on immune responses against COVID-19 and SARS-CoV-2 vaccination
M Golshani, J Hrdý - Vaccines, 2022 - mdpi.com
This article reviews the literature on SARS-CoV-2 pandemic and multiple sclerosis (MS).
The first part of the paper focuses on the current data on immunopathology of SARS-CoV-2 …
The first part of the paper focuses on the current data on immunopathology of SARS-CoV-2 …
Clinical onset and multiple sclerosis relapse after SARS-CoV-2 infection
A Pignolo, M Aprile, C Gagliardo, GM Giammanco… - Neurology …, 2021 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been
associated with several neurological disorders including headache, facial palsy …
associated with several neurological disorders including headache, facial palsy …
Coronaviruses and their relationship with multiple sclerosis: is the prevalence of multiple sclerosis going to increase after the Covid-19 pandemia?
The purpose of this review is to examine whether there is a possible (etiological/triggering)
relationship between infection with various Coronaviruses, including Severe Acute …
relationship between infection with various Coronaviruses, including Severe Acute …
Multiple sclerosis and SARS-CoV-2: has the interplay started?
G Bellucci, V Rinaldi, MC Buscarinu, R Reniè… - Frontiers in …, 2021 - frontiersin.org
Current knowledge on Multiple Sclerosis (MS) etiopathogenesis encompasses complex
interactions between the host's genetic background and several environmental factors that …
interactions between the host's genetic background and several environmental factors that …
Immunology of COVID‐19 and disease‐modifying therapies: The good, the bad and the unknown
Objective The outbreak of the SARS‐CoV‐2 pandemic, caused by a previously unknown
infectious agent, posed unprecedented challenges to healthcare systems and unmasked …
infectious agent, posed unprecedented challenges to healthcare systems and unmasked …
Interferon Beta-1a treatment promotes SARS-CoV-2 mRNA vaccine response in multiple sclerosis subjects
GT Maniscalco, V Manzo, AL Ferrara, A Perrella… - Multiple sclerosis and …, 2022 - Elsevier
Background Several concerns exist on the immunogenicity of SARS-CoV-2 vaccines in
multiple sclerosis (MS) subjects due to their immunomodulating disease modifying therapies …
multiple sclerosis (MS) subjects due to their immunomodulating disease modifying therapies …
The humoral response to SARS-COV-2 vaccines in MS patients: A case series exploring the impact of DMT, lymphocyte count, immunoglobulins, and vaccine type
C Jakubecz, XS Zhang, S Woodson, A Serra… - Multiple Sclerosis and …, 2022 - Elsevier
Abstract Background & Objectives Certain disease modifying therapies may negatively
impact the humoral response to SARS-CoV-2 vaccines. Many MS related clinical …
impact the humoral response to SARS-CoV-2 vaccines. Many MS related clinical …